ID   ZFP62_HUMAN             Reviewed;         900 AA.
AC   Q8NB50; B4DIP6; B4E0N3; B5MDX6; B7ZVZ2; B9EIP6; E9PFT8; J3QTA9;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 3.
DT   28-JUN-2023, entry version 176.
DE   RecName: Full=Zinc finger protein 62 homolog;
DE            Short=Zfp-62;
GN   Name=ZFP62;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 173-900 (ISOFORM 2), NUCLEOTIDE SEQUENCE [LARGE SCALE
RP   MRNA] OF 1-145 (ISOFORM 3), AND VARIANTS ILE-34 AND LYS-698.
RC   TISSUE=Brain, Hippocampus, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 186-900 (ISOFORM 1), AND VARIANT
RP   LYS-698.
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 186-900 (ISOFORM 1), AND VARIANT
RP   LYS-698.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65 AND LYS-82, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-82, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-82, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-48; LYS-62; LYS-65;
RP   LYS-82; LYS-92; LYS-587; LYS-748 AND LYS-882, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May play a role in differentiating skeletal muscle.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NB50-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NB50-2; Sequence=VSP_010136;
CC       Name=3;
CC         IsoId=Q8NB50-3; Sequence=VSP_045257;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI40762.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC03691.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG58558.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical GTG valine codon.; Evidence={ECO:0000305};
CC       Sequence=CAI46133.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091550; BAC03691.1; ALT_INIT; mRNA.
DR   EMBL; AK295714; BAG58558.1; ALT_SEQ; mRNA.
DR   EMBL; AK303450; BAG64495.1; -; mRNA.
DR   EMBL; DA323041; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC022413; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL832408; CAI46133.1; ALT_INIT; Transcribed_RNA.
DR   EMBL; BC140761; AAI40762.1; ALT_INIT; mRNA.
DR   EMBL; BC171780; AAI71780.1; -; mRNA.
DR   CCDS; CCDS47357.2; -. [Q8NB50-3]
DR   CCDS; CCDS54955.1; -. [Q8NB50-1]
DR   RefSeq; NP_001166109.1; NM_001172638.1. [Q8NB50-1]
DR   RefSeq; NP_689496.4; NM_152283.4. [Q8NB50-3]
DR   RefSeq; XP_016865199.1; XM_017009710.1.
DR   RefSeq; XP_016865200.1; XM_017009711.1.
DR   RefSeq; XP_016865201.1; XM_017009712.1.
DR   RefSeq; XP_016865202.1; XM_017009713.1.
DR   RefSeq; XP_016865203.1; XM_017009714.1.
DR   RefSeq; XP_016865204.1; XM_017009715.1.
DR   RefSeq; XP_016865206.1; XM_017009717.1.
DR   AlphaFoldDB; Q8NB50; -.
DR   SMR; Q8NB50; -.
DR   BioGRID; 569091; 68.
DR   IntAct; Q8NB50; 26.
DR   STRING; 9606.ENSP00000423820; -.
DR   GlyGen; Q8NB50; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8NB50; -.
DR   PhosphoSitePlus; Q8NB50; -.
DR   BioMuta; ZFP62; -.
DR   DMDM; 327478553; -.
DR   EPD; Q8NB50; -.
DR   jPOST; Q8NB50; -.
DR   MassIVE; Q8NB50; -.
DR   MaxQB; Q8NB50; -.
DR   PaxDb; Q8NB50; -.
DR   PeptideAtlas; Q8NB50; -.
DR   ProteomicsDB; 72735; -. [Q8NB50-1]
DR   ProteomicsDB; 72736; -. [Q8NB50-2]
DR   Antibodypedia; 53012; 48 antibodies from 10 providers.
DR   DNASU; 643836; -.
DR   Ensembl; ENST00000502412.2; ENSP00000423820.1; ENSG00000196670.14. [Q8NB50-1]
DR   Ensembl; ENST00000512132.5; ENSP00000426193.1; ENSG00000196670.14. [Q8NB50-3]
DR   GeneID; 643836; -.
DR   KEGG; hsa:643836; -.
DR   MANE-Select; ENST00000502412.2; ENSP00000423820.1; NM_001172638.2; NP_001166109.1.
DR   UCSC; uc011dhe.3; human. [Q8NB50-1]
DR   AGR; HGNC:23241; -.
DR   CTD; 643836; -.
DR   GeneCards; ZFP62; -.
DR   HGNC; HGNC:23241; ZFP62.
DR   HPA; ENSG00000196670; Low tissue specificity.
DR   MIM; 610281; gene.
DR   neXtProt; NX_Q8NB50; -.
DR   OpenTargets; ENSG00000196670; -.
DR   PharmGKB; PA134969387; -.
DR   VEuPathDB; HostDB:ENSG00000196670; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162750; -.
DR   HOGENOM; CLU_002678_17_3_1; -.
DR   InParanoid; Q8NB50; -.
DR   OMA; GNTESKW; -.
DR   OrthoDB; 4879638at2759; -.
DR   PhylomeDB; Q8NB50; -.
DR   TreeFam; TF343410; -.
DR   PathwayCommons; Q8NB50; -.
DR   SignaLink; Q8NB50; -.
DR   BioGRID-ORCS; 643836; 7 hits in 1181 CRISPR screens.
DR   ChiTaRS; ZFP62; human.
DR   GenomeRNAi; 643836; -.
DR   Pharos; Q8NB50; Tdark.
DR   PRO; PR:Q8NB50; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8NB50; protein.
DR   Bgee; ENSG00000196670; Expressed in ganglionic eminence and 186 other tissues.
DR   ExpressionAtlas; Q8NB50; baseline and differential.
DR   Genevisible; Q8NB50; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 26.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24377; IP01015P-RELATED; 1.
DR   PANTHER; PTHR24377:SF938; ZINC FINGER PROTEIN 429-RELATED; 1.
DR   Pfam; PF00096; zf-C2H2; 22.
DR   Pfam; PF13912; zf-C2H2_6; 3.
DR   SMART; SM00355; ZnF_C2H2; 26.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 16.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 25.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 26.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..900
FT                   /note="Zinc finger protein 62 homolog"
FT                   /id="PRO_0000047305"
FT   ZN_FING         225..247
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         253..275
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         281..303
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         309..331
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         337..359
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         365..387
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         393..415
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         421..443
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         449..471
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         477..499
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         505..527
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         533..555
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         561..583
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         589..611
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         617..639
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         645..667
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         673..695
FT                   /note="C2H2-type 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         701..723
FT                   /note="C2H2-type 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         729..751
FT                   /note="C2H2-type 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         757..779
FT                   /note="C2H2-type 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         785..807
FT                   /note="C2H2-type 21"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         813..834
FT                   /note="C2H2-type 22"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         840..862
FT                   /note="C2H2-type 23"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..97
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..71
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        5
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        48
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        62
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        65
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        82
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        587
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        748
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        882
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..33
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045257"
FT   VAR_SEQ         339..534
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010136"
FT   VARIANT         34
FT                   /note="M -> I (in dbSNP:rs705441)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_064881"
FT   VARIANT         698
FT                   /note="R -> K (in dbSNP:rs168726)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_064882"
FT   CONFLICT        321
FT                   /note="C -> R (in Ref. 1; BAC03691)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        690
FT                   /note="N -> I (in Ref. 1; BAG64495)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        800
FT                   /note="L -> F (in Ref. 1; BAG58558)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   900 AA;  102511 MW;  0C1D915D03FBBE67 CRC64;
     MSHLKTSTED EEPTEEYENV GNAASKWPKV EDPMPESKVG DTCVWDSKVE NQQKKPVENR
     MKEDKSSIRE AISKAKSTAN IKTEQEGEAS EKSLHLSPQH ITHQTMPIGQ RGSEQGKRVE
     NINGTSYPSL QQKTNAVKKL HKCDECGKSF KYNSRLVQHK IMHTGEKRYE CDDCGGTFRS
     SSSLRVHKRI HTGEKPYKCE ECGKAYMSYS SLINHKSTHS GEKNCKCDEC GKSFNYSSVL
     DQHKRIHTGE KPYECGECGK AFRNSSGLRV HKRIHTGEKP YECDICGKTF SNSSGLRVHK
     RIHTGEKPYE CDECGKAFIT CRTLLNHKSI HFGDKPYKCD ECEKSFNYSS LLIQHKVIHT
     GEKPYECDEC GKAFRNSSGL IVHKRIHTGE KPYKCDVCGK AFSYSSGLAV HKSIHPGKKA
     HECKECGKSF SYNSLLLQHR TIHTGERPYV CDVCGKTFRN NAGLKVHRRL HTGEKPYKCD
     VCGKAYISRS SLKNHKGIHL GEKPYKCSYC EKSFNYSSAL EQHKRIHTRE KPFGCDECGK
     AFRNNSGLKV HKRIHTGERP YKCEECGKAY ISLSSLINHK SVHPGEKPFK CDECEKAFIT
     YRTLTNHKKV HLGEKPYKCD VCEKSFNYTS LLSQHRRVHT REKPYECDRC EKVFRNNSSL
     KVHKRIHTGE RPYECDVCGK AYISHSSLIN HKSTHPGRTP HTCDECGKAF FSSRTLISHK
     RVHLGEKPFK CVECGKSFSY SSLLSQHKRI HTGEKPYVCD RCGKAFRNSS GLTVHKRIHT
     GEKPYECDEC GKAYISHSSL INHKSVHQGK QPYNCECGKS FNYRSVLDQH KRIHTGKKPY
     RCNECGKAFN IRSNLTKHKR THTGEESLNV IYVGSYSGTS QKRTYEGGNA LDGGRMRMPL
//
